CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-01 | Henn Matthew R. | Exercise or conversion · Stock Option (Right to Buy) | −27,562 | 45,938 | ||
| 2020-11-23 | Berenson Stephen Director | Other acquisition | +3,589 | 3,589 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −3,587,820 | 4,434,600 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −642,180 | 1,283,282 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −966,234 | 0 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −1,186,310 | 3,258,134 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −1,481,481 | 2,962,963 | ||
| 2020-11-23 | Flagship Ventures Fund IV General Partner LLC 10% owner | Other disposition | −43,154 | 0 | ||
| 2020-10-19 | Ege David S. | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-06-29 | Young Teresa L. | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-06-18 | Biondi Paul Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Berenson Stephen Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Graves Kurt Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Zausner Meryl Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Kender Richard N Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Dere Willard H Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-06-18 | Behar Gregory Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 |
Page 23 of 23 · 458 trades